About Toby Maher
About Toby Maher
Living with Idiopathic Pulmonary Fibrosis (IPF)
Toby Maher on his respiratory disorders research - F1000 Blogs
Dr. Toby Maher, MD – Los Angeles, CA | Pulmonology
Rituximab 'a reasonable alternative to cyclophosphamide' to improve ILD-CTD | MDedge Rheumatology
Toby Maher - Professor of Clinical Medicine - Keck Medicine of USC | LinkedIn
Toby Maher - Buildxact | LinkedIn
Toby Maher (@TobyMMaher) / X
American Thoracic Society - Webinar on Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes. Faculty: Toby Maher MD + Mary Beth Scholand MD Supported by an educational grant from Genentech, a
Multicenter trial backs pirfenidone for unclassifiable interstitial lung disease | CHEST Physician
Toby Maher (@TobyMMaher) / X
TOBY MAHER (@tobycmaher) • Instagram photos and videos
Professor Toby Maher – NeRRe Therapeutics
Toby Maher - Professor of Clinical Medicine - Keck Medicine of USC | LinkedIn
Toby Maher - Medical Advisor at Lung Therapeutics | The Org
Toby MAHER | NIHR Clinician Scientist | MB MSc PhD | Imperial College London, London | Imperial | National Heart and Lung Institute | Research profile
Toby Maher (@TobyMMaher) / X
Toby Maher - Professor of Clinical Medicine - Keck Medicine of USC | LinkedIn
News & Media
Toby Maher (@TobyMMaher) / X
Stream My interview with Dr Toby Maher about the little known lung disease IPF by Giles Draper | Listen online for free on SoundCloud
EE Footage - Toby Maher | Boehringer Ingelheim
Toby Maher - Professor of Clinical Medicine - Keck Medicine of USC | LinkedIn
Iron is good for your breathing. We've all heard of an iron lung, but it… | by Research at the British Lung Foundation | Medium
